A prospective single centre single arm open label study of the long term use of a LHRH agonist (Decapeptyl SR 11.25mg) in combination with livial add-back therapy in the management of chronic cyclical pelvic pain in pre-menopausal women
Phase of Trial: Phase IV
Latest Information Update: 05 Jul 2016
At a glance
- Drugs Triptorelin (Primary) ; Tibolone
- Indications Pelvic pain
- Focus Therapeutic Use
- Sponsors Ipsen
- 01 Jul 2016 Status changed from active, no longer recruiting to completed.
- 27 Feb 2015 Status changed from recruiting to active, no longer recruiting according to the United Kingdom Clinical Research Network record.
- 25 Jan 2014 Accrual to date is 77% according to United Kingdom Clinical Research Network.